Lantern Pharma Inc. Price-FCF Ratio
The price-to-free-cash-flow (P/FCF) ratio tells you how many dollars investors pay for each dollar of cash a company generates after paying for its capital spending. It is market capitalization divided by free cash flow over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher ratio means investors are paying more for each dollar of free cash flow; a negative ratio means the company spent more cash than it generated over those quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
- Lantern Pharma Inc. price-fcf ratio for the quarter ending 2025-12-31 was -2.16, a change of -0.23 year-over-year.
- Lantern Pharma Inc. price-fcf ratio for the quarter ending 2025-09-30 was -2.85, a change of -0.56 year-over-year.
- Lantern Pharma Inc. price-fcf ratio for the quarter ending 2025-06-30 was -1.94, a change of 1.35 year-over-year.
- Lantern Pharma Inc. price-fcf ratio for the quarter ending 2025-03-31 was -2, a change of 4.93 year-over-year.
- Lantern Pharma Inc. price-fcf ratio for fiscal 2025 was -2.16, a change of -0.23 from fiscal 2024.
- Lantern Pharma Inc. price-fcf ratio for fiscal 2024 was -1.93, a change of 1.26 from fiscal 2023.
- Lantern Pharma Inc. price-fcf ratio for fiscal 2023 was -3.19.
- Available history
- 2023-06-30 to 2025-12-31
- Data captured
Historical Price-FCF Ratio
Annual Price-FCF Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |